Rudi A. J. O. Dierckx

Rudi A. J. O. Dierckx

Auto-generated profile, based on publicly available information

Rudi A. J. O. Dierckx

Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2021 in Journal of Neuroscience Research
Verified
Journal Article
Open access
PDF file
NGNafiseh Ghazanfari
Nafiseh Ghazanfari
AWAren van Waarde
Aren van Waarde
RDRudi A. J. O. Dierckx
Rudi A. J. O. Dierckx
JDJanine Doorduin
Janine Doorduin
Erik de VriesErik de Vries
Erik de Vries
Purpose: Reactive microglia are an important hallmark of neuroinflammation. Reactive microglia release various inflammatory mediators, such as cytokines, chemokines, and prostaglandins, which are produced by enzymes like cyclooxygenases (COX). The inducible COX‐2 subtype has been associated with inflammation, whereas the constitutively expressed COX‐1 subtype is generally considered as a housekeeping enzyme. However, recent evidence suggests that COX‐1 can also be upregulated and may play a prominent role in the brain during neuroinflammation. In this review, we summarize the evidence that supports this involvement of COX‐1. Methods: Five databases were used to retrieve relevant studies that addressed COX‐1 in the context of neuroinflammation. The search resulted in 32 articles, describing in vitro, in vivo, post mortem, and in vivo imaging studies that specifically investigated the COX‐1 isoform under such conditions. Results: Reviewed literature generally indicated that the overexpression of COX‐1 was induced by an inflammatory stimulus, which resulted in an increased production of prostaglandin E2. The pharmacological inhibition of COX‐1 was shown to suppress the induction of inflammatory mediators like prostaglandin E2. Positron emission tomography (PET) imaging studies in animal models confirmed the overexpression of COX‐1 during neuroinflammation. The same imaging method, however, could not detect any upregulation of COX‐1 in patients with Alzheimer's disease. Conclusion: Taken together, studies in cultured cells and living rodents suggest that COX‐1 is involved in neuroinflammation. Most postmortem studies on human brains indicate that the concentration of COX‐1‐expressing microglial cells is increased near sites of inflammation. However, evidence for the involvement of COX‐1 in neuroinflammation in the living human brain is still largely lacking.

14 April 2022 in European Radiology
Verified
Journal Article
Open access
PDF file
JBJeroen Bleker
Jeroen Bleker
Thomas C. KweeThomas C. Kwee
Thomas C. Kwee
DRDennis Rouw
Dennis Rouw
CRChristian Roest
Christian Roest
JBJaap Borstlap
Jaap Borstlap
Derya YakarDerya Yakar
Derya Yakar
Objectives: To determine the value of a deep learning masked (DLM) auto-fixed volume of interest (VOI) segmentation method as an alternative to manual segmentation for radiomics-based diagnosis of clinically significant (CS) prostate cancer (PCa) on biparametric magnetic resonance imaging (bpMRI). Materials and methods: This study included a retrospective multi-center dataset of 524 PCa lesions (of which 204 are CS PCa) on bpMRI. All lesions were both semi-automatically segmented with a DLM auto-fixed VOI method (averaging < 10 s per lesion) and manually segmented by an expert uroradiologist (averaging 5 min per lesion). The DLM auto-fixed VOI method uses a spherical VOI (with its center at the location of the lowest apparent diffusion coefficient of the prostate lesion as indicated with a single mouse click) from which non-prostate voxels are removed using a deep learning–based prostate segmentation algorithm. Thirteen different DLM auto-fixed VOI diameters (ranging from 6 to 30 mm) were explored. Extracted radiomics data were split into training and test sets (4:1 ratio). Performance was assessed with receiver operating characteristic (ROC) analysis. Results: In the test set, the area under the ROC curve (AUCs) of the DLM auto-fixed VOI method with a VOI diameter of 18 mm (0.76 [95% CI: 0.66–0.85]) was significantly higher (p = 0.0198) than that of the manual segmentation method (0.62 [95% CI: 0.52–0.73]). Conclusions: A DLM auto-fixed VOI segmentation can provide a potentially more accurate radiomics diagnosis of CS PCa than expert manual segmentation while also reducing expert time investment by more than 97%. Key Points: • Compared to traditional expert-based segmentation, a deep learning mask (DLM) auto-fixed VOI placement is more accurate at detecting CS PCa. • Compared to traditional expert-based segmentation, a DLM auto-fixed VOI placement is faster and can result in a 97% time reduction. • Applying deep learning to an auto-fixed VOI radiomics approach can be valuable.


4 June 2022 in Ageing Research Reviews
Verified
Journal Article
Open access
SMSofia Marcolini
Sofia Marcolini
IFIngeborg Frentz
Ingeborg Frentz
CSCarlos A. Sanchez-Catasus
Carlos A. Sanchez-Catasus
JMJaime Daniel Mondragón
Jaime Daniel Mondragón
PFPaula Kopschina Feltes
Paula Kopschina Feltes
PDPeter Paul De Deyn
Peter Paul De Deyn
Cerebral perfusion dysfunctions are seen in the early stages of Alzheimer's disease (AD). We systematically reviewed the literature to investigate the effect of pharmacological and non-pharmacological interventions on cerebral hemodynamics in randomized controlled trials involving AD patients or Mild Cognitive Impairment (MCI) due to AD. Studies involving other dementia types were excluded. Data was searched in April 2021 on MEDLINE, Embase, and Web of Science. Risk of bias was assessed using Cochrane Risk of Bias Tool. A meta-synthesis was performed separating results from MCI and AD studies. 31 studies were included and involved 310 MCI and 792 CE patients. The MCI studies (n = 8) included physical, cognitive, dietary, and pharmacological interventions. The AD studies (n = 23) included pharmacological, physical interventions, and phytotherapy. Cerebral perfusion was assessed with PET, ASL, Doppler, fNIRS, DSC-MRI, Xe-CT, and SPECT. Randomization and allocation concealment methods and subject characteristics such as AD-onset, education, and ethnicity were missing in several papers. Positive effects on hemodynamics were seen in 75 % of the MCI studies, and 52 % of the AD studies. Inserting cerebral perfusion outcome measures, together with established AD biomarkers, is fundamental to target all disease mechanisms and understand the role of cerebral perfusion in AD.

13 September 2023 in Liver Transplantation
Verified
Journal Article
Closed access
WLWeihao Li
Weihao Li
RBReinoud Bokkers
Reinoud Bokkers
RDRudi A.J.O. Dierckx
Rudi A.J.O. Dierckx
HVHenkjan J Verkade
Henkjan J Verkade
DSDewey H. Sanders
Dewey H. Sanders
HDHubert P.J. van der Doef
Hubert P.J. van der Doef
Objectives: This study aimed to evaluate the effectiveness of different treatments for hepatic artery thrombosis (HAT) and hepatic artery stenosis (HAS) after pediatric liver transplantation (pLT). Methods: We systematically reviewed studies published since 2000 that investigated the management of HAT and/or HAS after pLT. Studies with a minimum of 5 patients in one of the treatments methods were included. The primary outcomes were technical success rate and graft and patient survival. The secondary outcomes were hepatic artery patency, complications, and incidence of HAT and HAS. Results: Of 3570 studies, we included 19 studies with 328 patients. The incidence was 6.2% for HAT and 4.1% for HAS. Patients with an early HAT treated with surgical revascularization had a median graft survival of 45.7% (interquartile range [IQR], 30.7%-60%) and a patient survival of 61.3% (IQR, 58.7%–66.9%) compared with the other treatments (conservative, endovascular revascularization, or retransplantation). As for HAS, endovascular and surgical revascularization groups had a patient survival of 85.7% and 100% (IQR, 85%-100%), respectively. Conclusions: Despite various treatment methods, HAT after pLT remains a significant issue that has profound effects on the patient and graft survivals. Current evidence is insufficient to determine the most effective treatment for preventing graft failure.

8 May 2017 in International Journal of Oncology
Verified
Journal Article
Open access
FGFilippo Galli
Filippo Galli
MAMarco Artico
Marco Artico
STSamanta Taurone
Samanta Taurone
IMIsabella Manni
Isabella Manni
EBEnrica Bianchi
Enrica Bianchi
Alberto SignoreAlberto Signore
Alberto Signore
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications